MDMAR

3',4'-Methylenedioxy-4-methylaminorex (MDMAR) is a recreational designer drug from the substituted aminorex family, with monoamine releasing effects.[1][2][3]

3',4'-Methylenedioxy-4-methylaminorex
Identifiers
  • 5-(1,3-benzodioxol-5-yl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
PubChem CID
Chemical and physical data
FormulaC11H12N2O3
Molar mass220.228 g·mol−1
3D model (JSmol)
  • CC1C(OC(=N1)N)C2=CC3=C(C=C2)OCO3
  • InChI=1S/C11H12N2O3/c1-6-10(16-11(12)13-6)7-2-3-8-9(4-7)15-5-14-8/h2-4,6,10H,5H2,1H3,(H2,12,13)
  • Key:JFKNBDXNCLMRPL-UHFFFAOYSA-N

See also

References

  1. McLaughlin G, Morris N, Kavanagh PV, Power JD, Twamley B, O'Brien J, et al. (July 2015). "Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)". Drug Testing and Analysis. 7 (7): 555–64. doi:10.1002/dta.1732. PMC 5331736. PMID 25331619.
  2. Zawilska JB, Andrzejczak D (December 2015). "Next generation of novel psychoactive substances on the horizon - A complex problem to face". Drug and Alcohol Dependence. 157: 1–17. doi:10.1016/j.drugalcdep.2015.09.030. PMID 26482089.
  3. Maier J, Mayer FP, Brandt SD, Sitte HH (October 2018). "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience. 9 (10): 2484–2502. doi:10.1021/acschemneuro.8b00415. PMC 6287711. PMID 30269490.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.